EVOKE PLC/ GI000A0F6407 /
| 2024-06-05 4:05:30 PM | Chg. -2.15 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 86.00GBX | -2.44% | 3,379 Turnover(GBP): 2,907.3530 |
-Bid Size: - | -Ask Size: - | 86.95 | 86.00 |
GlobeNewswire
1:00 PM
Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying ...
GlobeNewswire
05-30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire
05-29
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2...
GlobeNewswire
05-21
Numi Organic Tea Launches Relax and Regenerate Herbal Supplement Tea Line Featuring Damiana
GlobeNewswire
05-20
Vancouver Video Production by Cinematix Media Launches Video Production Services in Canada
GlobeNewswire
05-16
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care ...
GlobeNewswire
05-15
Blade and Emirates partner to enable seamless booking of flights between Dubai and Monaco
GlobeNewswire
05-14
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
05-14
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-14
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-09
Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
05-07
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and W...
GlobeNewswire
05-03
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
05-02
Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by...
